Aoyama Zaisan Networks Company,Limited Logo

Aoyama Zaisan Networks Company,Limited

Consulting on inheritance and business succession for individuals and corporations.

8929 | T

Overview

Corporate Details

ISIN(s):
JP3825750007
LEI:
Country:
Japan
Address:
港区赤坂八丁目4番14号青山タワープレイス3階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Aoyama Zaisan Networks Company, Limited is a Japanese consulting firm specializing in comprehensive property and asset management solutions. The company primarily offers two types of services: inheritance consulting for individual asset owners and business succession consulting for corporations. It leverages its expertise in real estate, financial products, and related services to provide tailored solutions for asset transfer, maintenance, and operations. The firm's service portfolio also includes real estate solutions and property investment support in the USA.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-07 08:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-08-07 08:31
Interim Report
半期報告書-第35期(2025/01/01-2025/12/31)
Japanese 201.7 KB
2025-06-11 06:18
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.3 KB
2025-05-09 05:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-04-07 03:24
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-03-27 07:51
Registration Form
確認書
Japanese 8.2 KB
2025-03-27 07:51
Governance Information
内部統制報告書-第34期(2024/01/01-2024/12/31)
Japanese 22.0 KB
2025-03-27 07:50
Annual Report
有価証券報告書-第34期(2024/01/01-2024/12/31)
Japanese 2.0 MB
2025-03-27 07:46
Post-Annual General Meeting Information
臨時報告書
Japanese 23.4 KB
2025-03-10 08:44
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-02-10 07:56
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-01-15 08:52
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.1 KB
2024-12-12 06:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.9 KB
2024-11-14 08:01
M&A Activity
臨時報告書
Japanese 64.0 KB
2024-08-08 08:03
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all Aoyama Zaisan Networks Company,Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aoyama Zaisan Networks Company,Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Aoyama Zaisan Networks Company,Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BeyondSpring Inc. Logo
Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.
United States of America BYSI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.
United States of America BIAF
BIO-FD&C CO.,LTD. Logo
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea 251120
BioNexus Gene Lab Corp Logo
Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.
United States of America BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.
France ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
Belgium BIOS
BIOTECH Logo
Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.
Spain BST
BiotoxtechCo.,Ltd. Logo
A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.
South Korea 086040
Bolt Biotherapeutics, Inc. Logo
Developing immunotherapies that use antibody conjugates to help the immune system destroy cancer.
United States of America BOLT
Bonus BioGroup Ltd. Logo
Develops cell therapies and tissue products for bone grafts and inflammation repair.
Israel BONS

Talk to a Data Expert

Have a question? We'll get back to you promptly.